OMFRELA
associated with 29 other trademarks
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, hear...

Words that describe this trademark:

prevention cardiovascular disease  cardiovascular disease  disease sclerosis  treatment prevention  diabetic nephropathy  pharmaceutical preparations  preparations  atherosclerosis  sclerosis  nephropathy 

Serial Number:

79167962

Mark:

OMFRELA

Status:

Status Date:

05-20-2022

Filing Date:

Registration Number:

4843523

Registration Date:

11-03-2015

Goods and Services:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, leukemia, metastasis, autoimmune disease, rheumatoid arthritis, allergy, bacterial infection, viral infection, fungal infection, inflammation, sepsis, spinal cord injury, musculoskeletal disorders, pain, central nervous system disease, neurological disease, mood disorders, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease, constipation; vaccines; diagnostic reagents and contrast media for medical use

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

08-18-2015

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

LADAS & PARRY

Correspondent Name:

Recent Trademark filings by this company